79138125 - VALNEVA

Information

• Trademark
• 79138125

• Source

• Serial Number

  79138125

• Registration Number

  4686292

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 31, 2013
  11 years ago

• Registration Date

  February 17, 2015
  9 years ago

• Transaction Date

  May 22, 2024
  7 months ago

• Status Date

  November 30, 2020
  4 years ago

• Published for Opposition Date

  December 02, 2014
  10 years ago

• Location Date

  November 30, 2020
  4 years ago

• Status Code

  739

• Current Location

  GENERIC WEB UPDATE

  Employee Name

  BUONGIORNO, CHRISTOPHE

• Attorney Docket Number

  GPIT0128TUS

  Attorney Name

  Hope V. Shovein

  Law Office Assigned Location Code

  L20

• Owners

  • VALNEVA

Case File Statements

• GS0051: Pharmaceuticals for human and veterinary use for the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; antibodies and fragments thereof for use in disease testing; cell cultures, microorganisms and viruses for medical and veterinary use; diagnostic agents for medical, pharmaceutical and veterinary use; cells for medical or clinical use; culture media for cultivating microorganism cells for medical and veterinary use; adjuvants for medical or and veterinary use; pharmaceutical and veterinary preparations for medical, pharmaceutical and veterinary use, namely, preparations of encapsulated cells which release antibodies, living cells and microorganisms, vaccines, viral vectors, proteins, peptides, enzymes, nucleic acids or pharmaceutically active compounds for the treatment of cancer, auto-immune disorders, infectious diseases, inflammatory diseases, neurological and genetic disorders, bowel diseases, and digestion problems
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Chemicals for use in industry, science and agriculture, except fungicides, herbicides, insecticides and parasiticides; molecules from biotechnologies, namely, proteins in raw material for industrial use, scientific or medical research; cells and cell lines for use in scientific, laboratory, or medical research; nucleic acids for laboratory use; proteins in raw material form for scientific and medical research; recombinant proteins in raw material form for scientific and medical research; Biomedical compounds, namely, peptide substrates and peptide antigens used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biochemical preparations derived from blood serum used as growth promoters in tissue cultures and microbiological media; Biochemicals, namely, antibodies and fragments thereof for in vitro scientific or research use; Chemicals for use in biotechnological product development; Cultures of microorganisms other than for medical and veterinary use; Biological preparations and bacteriological preparations for use in cell cultures other than for medical or veterinary use
• GS0421: Scientific research services for medical purposes in the fields of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research for medical, pharmaceutical and veterinary purposes in the fields of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research, in particular, in the fields of biology, cellular and molecular biology, biotechnology, bacteriology, immunology, genetics, medicine, pharmacology, virology, chemistry; scientific research relating to vaccines, antibiotics and immunological products for human and veterinary use; research and development of new products for others; testing, analysis, and evaluation of the goods of others to assure compliance with industry standards in the scientific, medical and veterinary fields; development and design of laboratory instruments for scientific and industrial research, in particular, to obtain and prepare cells, cell lines, viruses, proteins, animal and human materials; development of vaccines, antibiotics and immunological products for human and veterinary use; scientific and technological services, namely, diagnostic and prognostic analyses in the fields of cells, cell lines, animal and human materials, microorganisms, molecules for scientific purposes; scientific research, namely, preparation of scientific experts opinions reports

Case File Event Statements

• 11/19/2013 - 11 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 11/11/2013 - 11 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 11/13/2013 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/13/2013 - 11 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/15/2013 - 11 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/16/2013 - 11 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 10/9/2014 - 10 years ago

  16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 11/20/2013 - 11 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 11/20/2013 - 11 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 12/10/2013 - 11 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 4/9/2014 - 10 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/9/2014 - 10 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/9/2014 - 10 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/24/2014 - 10 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 4/24/2014 - 10 years ago

  14 - FINAL REFUSAL E-MAILED Type: GNFR

• 4/24/2014 - 10 years ago

  15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 10/9/2014 - 10 years ago

  17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/9/2014 - 10 years ago

  18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/9/2014 - 10 years ago

  19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/9/2014 - 10 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/17/2015 - 9 years ago

  26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 10/28/2014 - 10 years ago

  21 - ASSIGNED TO LIE Type: ALIE

• 10/29/2014 - 10 years ago

  22 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/12/2014 - 10 years ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/2/2014 - 10 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/2/2014 - 10 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 5/17/2015 - 9 years ago

  27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 6/29/2015 - 9 years ago

  28 - FINAL DISPOSITION PROCESSED Type: FIMP

• 6/29/2015 - 9 years ago

  29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 7/31/2015 - 9 years ago

  30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 12/22/2016 - 8 years ago

  31 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 12/13/2018 - 6 years ago

  32 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 9/26/2019 - 5 years ago

  33 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 2/17/2020 - 4 years ago

  34 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 7/8/2020 - 4 years ago

  35 - TEAS SECTION 71 & 15 RECEIVED Type: ES75

• 11/24/2020 - 4 years ago

  36 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 11/30/2020 - 4 years ago

  37 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A

• 4/7/2023 - a year ago

  42 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL

• 11/30/2020 - 4 years ago

  38 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75

• 10/1/2022 - 2 years ago

  39 - RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED Type: RHRD

• 10/15/2022 - 2 years ago

  40 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 11/3/2022 - 2 years ago

  41 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN

• 4/25/2024 - 7 months ago

  46 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN

• 2/17/2024 - 10 months ago

  44 - RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED Type: RHRD

• 2/17/2024 - 10 months ago

  43 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4

• 2/25/2024 - 9 months ago

  45 - RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED Type: RHRD

• 5/22/2024 - 7 months ago

  47 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN